Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Chitogen
AddedFeb 16, 2024
UpdatedJun 18, 2026
Chitogen

Chitogen

Seed

Chitogen, a Minneapolis-based medical device company, specializes in manufacturing and selling topical hemostats and wound care products.

HQ
Plymouth, MN, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Chitogen, founded in 2007 and based in Minneapolis, Minnesota, is a medical device company dedicated to designing, manufacturing, and selling topical hemostats and wound care products. The company's mission is to provide innovative solutions for rapid hemostasis and improved patient comfort. Chitogen's product line includes the SoftSeal®-STF, SoftSeal®-STFR, D-Seal®, and TRAUMASTAT™, all of which leverage chitosan technology to accelerate blood clotting and reduce compression time.

Chitogen's core team comprises experienced professionals from the medical device startup and wound care sectors. The company has successfully commercialized its initial products, gaining recognition for its advanced hemostatic solutions. Notable investors and affiliations include key figures in the medical device industry, contributing to Chitogen's credibility and growth. The impact of Chitogen's products is evident in their widespread adoption for safe and quick bleeding control, enhancing patient outcomes in various medical settings.

Chitogen - Similar Companies

Axio Biosolutions logo

Axio Biosolutions

axiobio.com

KitoTech Medical logo

KitoTech Medical

Protege Biomedical logo

Protege Biomedical

Cresilon logo

Cresilon

cresilon.com

Sealonix logo

Sealonix

sealonix.com

Innovative Trauma Care logo

Innovative Trauma Care

CloSys logo

CloSys

EndoShunt Medical logo

EndoShunt Medical

endoshunt.com

Cellphire logo

Cellphire

cellphire.com

St. Teresa Medical logo

St. Teresa Medical

Opus KSD logo

Opus KSD

subq-it.com

XaTek logo

XaTek

clotchip.com

Biofisica logo

Biofisica

biofisica.com

Organogenesis Holdings logo

Organogenesis Holdings

organogenesis.com

Compression Works logo

Compression Works

Chitogen - Quick Facts

Who are Chitogen's competitors?

Companies similar to Chitogen include Axio Biosolutions, KitoTech Medical, Protege Biomedical and Cresilon.

When was Chitogen founded?

Chitogen was founded in 2007.

Where is Chitogen's headquarters located?

Chitogen's headquarters is located in Plymouth, MN, US.

When was Chitogen's last funding round?

Chitogen's most recent funding round was for $523.5k (USD) in October 2018.

How much has Chitogen raised to-date?

As of Oct 9, 2018, Chitogen has raised a total of $2.3M (USD).

How many employees does Chitogen have?

Chitogen has 30 employees as of Feb 5, 2024.

Chitogen - Classification

Industry
  • Hardware
  • Retail
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Main Product
  • Hemostats
  • Wound Care
Tags
  • Healthtech
  • Medical Devices
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified